Globe Life Inc. $GL Shares Sold by Pzena Investment Management LLC
Pzena Investment Management LLC reduced its stake in Globe Life Inc. by 2.2% in the fourth quarter, though it still holds a significant position. Insiders, including the CEO and an EVP, also sold a substantial number of shares recently. Despite mixed quarterly results, analysts maintain a "Buy" rating for Globe Life with an average target price of $173.22, and the company announced a quarterly dividend of $0.33 per share.
Globe Life Inc. $GL Shares Purchased by Handelsbanken Fonder AB
Handelsbanken Fonder AB increased its stake in Globe Life Inc. by 23.1% in the fourth quarter, purchasing an additional 14,135 shares and bringing their total holding to 75,235 shares valued at approximately $10.5 million. The company reported quarterly EPS of $3.43 and revenue of $1.56 billion, with a 5.3% year-over-year revenue increase. Analysts currently rate Globe Life as a consensus "Buy" with an average price target of $173.22.
Globe Life stock (US37959E1029): Earnings and capital-return updates keep investors focused
Globe Life (US37959E1029) continues to hold investor attention due to its focus on life and supplemental health insurance, recent earnings reports, and capital return strategies within the U.S. market. The company's business model, driven by premiums, underwriting, and investment income, makes it a relevant stock for U.S. investors monitoring interest rates, consumer demand, and sector-specific financial health. Its performance hinges on operational variables like sales growth, claims experience, and capital allocation, with investors keenly watching how efficiently it converts insurance demand into durable earnings.
A Look At Burford Capital (BUR) Valuation After US Court Pause In $18b YPF Asset Tracing
Burford Capital's stock has faced pressure due to a US appeals court temporarily pausing asset tracing in the US$18 billion YPF litigation, introducing uncertainty about the award collection. Despite recent share price declines, the company trades at a reported 46% intrinsic discount with a "47.7% Undervalued" narrative, setting its fair value at around $8.94. This valuation hinges heavily on future case outcomes, consistent revenue expansion, and improved margins, with risks including further YPF case delays and potential regulatory tightening in litigation funding.
Morgan Stanley Adjusts Price Target on Globe Life to $181 From $176, Maintains Equalweight Rating
Morgan Stanley has increased its price target for Globe Life (GL) to $181 from $176, while maintaining an Equalweight rating on the stock. This adjustment reflects an updated outlook on the life and health insurance company. The news was published on May 21, 2026, by MT Newswires.
Top Globe Life Executive Offloads a Major Chunk of Company Stock
Globe Life's Executive Vice President and CFO, Thomas Peter Kalmbach, recently sold 11,903 shares of company stock worth over $1.86 million. This insider transaction comes as Globe Life has seen multiple analyst price target hikes following strong Q1 earnings and positive management guidance. TipRanks' AI Analyst, Spark, rates GL as an "Outperform" due to strong profitability, a sound balance sheet, and active capital returns, despite some headwinds.
Globe Life Inc. stock (US37959E1029): shares under pressure after short-seller report and regulatory scrutiny
Globe Life Inc. is facing pressure following a short-seller report alleging misconduct and subsequent regulatory scrutiny. Despite the allegations, which the company denies, Globe Life emphasizes its strong core US protection business and reaffirmed its 2024 earnings guidance. The situation highlights how non-fundamental events can affect trading in financial stocks, while the company's long-term risks include ongoing investigations and competitive pressures.
Globe Life EVP & CFO Kalmbach sells $1.86m in stock
Thomas Peter Kalmbach, EVP and CFO of Globe Life Inc. (NASDAQ: GL), sold 11,903 shares of company stock for approximately $1.86 million on May 19, 2026, after exercising employee stock options. The sales occurred while Globe Life's stock was trading near its 52-week high, though InvestingPro analysis suggests it remains undervalued. This news follows Globe Life's Q1 2026 earnings report, which met revenue expectations despite a slight EPS miss, and several analysts raising their price targets for the company.
Globe Life Insider Sold Shares Worth $1,864,186, According to a Recent SEC Filing
An insider at Globe Life has sold shares valued at $1,864,186, as reported in a recent SEC filing. This transaction indicates a significant divestment by a company insider. Further details would be in the full SEC report.
Globe Life EVP & CFO Kalmbach sells $1.86m in stock
Thomas Peter Kalmbach, EVP and CFO of Globe Life Inc., sold 11,903 shares of company stock for approximately $1.86 million, with shares trading near their 52-week high. Prior to this, Kalmbach acquired 15,000 shares through stock options. This follows Globe Life's Q1 2026 earnings report, which slightly missed EPS forecasts but met revenue expectations, leading several analysts to raise their price targets for the company.
Globe Life EVP & CFO Sold Shares Worth Over $1.8M
Thomas Peter Kalmbach, EVP & CFO of Globe Life, sold 11,903 shares of common stock at prices ranging from $156.145 to $157.05 per share, totaling $1,864,185. After this transaction, he directly owns 48,431 shares and indirectly owns 1,152 shares through a 401(k) plan. This information is based on an SEC Form 4 filing.
Globe Life (NYSE: GL) CFO sells shares after exercising stock options
Thomas Peter Kalmbach, EVP & CFO of Globe Life (NYSE: GL), exercised 15,000 employee stock options at $103.23 per share and subsequently sold 11,903 shares on the open market at an average price of $156.6148 per share. After these transactions, Kalmbach beneficially owns 48,431.7065 shares directly and 1,152.787 shares indirectly, with 20,000 employee stock options remaining. The transactions were disclosed in a Form 4 filing and indicate a net-sell for the day.
Globe Life Inc (GL) Stock Down 4.8% but Still Overvalued -- GF S
This article from GuruFocus.com reports that Globe Life Inc. (GL) stock has decreased by 4.8%. Despite this recent dip, the analysis concludes that the stock remains overvalued. The information is presented by GuruFocus, a financial website offering various analytical tools and data.
Globe Life stock (US37959E1029): SEC filing adds a fresh insider-sale angle
A recent SEC filing revealed a proposed sale of 35,000 Globe Life shares linked to a stock-option exercise, drawing investor attention to the insurance company's insider activity and governance. The company, which specializes in life and supplemental health insurance in the U.S., saw its shares trade slightly down at $156.34 following the news. While the filing itself doesn't indicate a fundamental shift, it adds a new data point for investors tracking insider transactions and highlights the importance of management's alignment with business execution in the defensive insurance industry.
Globe Life Inc (GL) Stock Down 4.8% but Still Overvalued -- GF Score: 86/100
Globe Life Inc (GL) saw its stock fall by 4.8% to $149.87, contributing to a 1-month drop, despite a 7.6% year-to-date gain and 23.7% increase over the past year. GuruFocus classified GL as 1.1% overvalued with a GF Score of 86/100, citing strong growth and momentum but weak financial strength and significant insider selling totaling $28.2 million. Investors are cautioned due to the overvaluation and insider selling activity, despite the stock trading below its historical P/E median.
Globe Life (NYSE: GL) proposed Rule 144 sale of 20,000 shares
Globe Life Inc. (NYSE: GL) has filed a Rule 144 notice for the proposed sale of 20,000 shares of common stock, stemming from a stock option exercise, with a proposed sale date of May 19, 2026. The filing also indicates a prior sale of 12,854 shares on May 5, 2026, generating $1,974,421.95. This notice serves as a regulatory notification of intent rather than a confirmation of the actual sale.
Globe Life (NYSE: GL) insider files to sell 35,000 shares after option exercise
Thomas Kalmbach, an insider at Globe Life Inc. (NYSE: GL), has filed a Form 144 to sell 35,000 shares of common stock following a stock option exercise on May 19, 2026. The filing also reveals previous sales in May 2026 totaling 27,427 shares, generating proceeds of over $4.1 million. The Securities Compliance Analyst described the filing as a routine notice of proposed resale by an affiliate.
Globe Life Inc. stock underperforms Tuesday when compared to competitors
Globe Life Inc. (GL) shares fell by 4.75% on Tuesday, closing at $149.87, despite a prior three-day winning streak. This underperformance occurred during a broader market decline, with the S&P 500 Index dropping 0.67% and the Dow Jones Industrial Average falling 0.65%.
Prudential takes majority hold in Indian life insurer
Prudential plc is acquiring a 75% stake in Bharti Life Insurance Company Limited for an upfront price of ₹3,500 crore (US$389 million), shifting its Indian business to a majority-controlled structure. This transaction is considered strategic for Prudential, as India is a key growth market and allows the company direct operational influence over products and distribution. Regulatory hurdles involve potentially reducing its stake in ICICI Prudential Life, with proceeds earmarked for growth initiatives and free surplus.
Globe Life (NYSE:GL) - Stock Analysis
This Simply Wall St article provides a comprehensive stock analysis of Globe Life (NYSE:GL), highlighting its current valuation, future growth prospects, past performance, financial health, and dividend information. It notes that GL is trading significantly below its fair value estimate, with earnings forecast to grow, but also points out risks such as a high level of debt and recent insider selling. The report includes recent news, analyst updates, insider transactions, and dividend announcements.
Globe Life Inc. stock (US37959E1029): insurer recovers after short-seller shock and posts solid Q1
Globe Life Inc. shares have rebounded after an April short-seller report caused a sell-off, with the company emphasizing strong financial reporting and compliance. The New York-listed life insurer also posted solid first-quarter 2026 results, maintaining profitability. Globe Life focuses on providing life and supplemental health insurance to middle-income households in the US, with revenue driven by premiums and investment income, and its stock offers US investors exposure to the domestic insurance market.
Globe Life stock hits all-time high at 156.97 USD By Investing.com
Globe Life Inc. stock has reached a new all-time high of $156.97, reflecting a 27.95% appreciation over the past year. Despite a slight miss in Q1 2026 EPS, analysts maintain a positive outlook, with several firms raising their price targets due to the company's strong cash flow generation and consistent dividend increases. The stock trades at an attractive PEG ratio, suggesting potential undervaluation.
Globe Life Inc. stock (US37959E1029): Investor focus after short-seller report, governance questions
Globe Life Inc. has been under intense scrutiny in 2024 following a short-seller report, subsequent lawsuits, and a rating downgrade, which has raised questions about its governance and business model. The company operates as a holding company for various insurance subsidiaries, focusing on life and supplemental health coverage for middle-income households in the US, with premium income from these policies and investment income driving its revenue. Despite its historically stable business model and capital return strategies, the ongoing controversies pose significant uncertainty and reputational risk, making it a critical case study for US investors observing corporate governance and market sentiment in the insurance sector.
MetLife stock (US59156R1086): earnings beat and analyst optimism keep the spotlight on the insurer
MetLife Inc. started 2026 with better-than-expected quarterly earnings, reporting an EPS of $2.42 against an analyst estimate of $2.27, demonstrating solid underwriting and investment income. Analyst sentiment is largely positive, with a "Moderate Buy" consensus and an average twelve-month price target of $95.15, suggesting a potential upside of approximately 19%. The article highlights MetLife's diversified business model, global reach, and the importance of US labor market trends and interest rates to its performance.
Globe Life Inc stock (US3765361038): Earnings momentum and scrutiny after short-seller attack
Globe Life Inc.'s stock has experienced volatility after a short-seller report in April 2024 and recent quarterly earnings. The article examines the US life insurer's business model, revenue drivers, recent earnings performance, and the impact of the short-seller allegations. It also discusses industry trends and why Globe Life matters to US investors, emphasizing its earnings resilience tempered by increased scrutiny.
Kinsale Capital Group Inc. Buys New Stake in FactSet Research Systems Inc. $FDS
Kinsale Capital Group Inc. has acquired a new stake in FactSet Research Systems Inc., purchasing 17,749 shares valued at approximately $5.15 million in the fourth quarter. This move comes as FactSet reported better-than-expected quarterly earnings and revenue, and increased its quarterly dividend. Despite this, analysts hold a cautious "Reduce" rating with an average price target of $279.85.
Northwestern Mutual Wealth Management Co. Has $123.35 Million Holdings in Globe Life Inc. $GL
Northwestern Mutual Wealth Management Co. significantly increased its stake in Globe Life Inc. (NYSE:GL) during the fourth quarter, acquiring an additional 879,391 shares to own a total of 881,919 shares valued at approximately $123.35 million. The firm now holds 1.11% of Globe Life's stock. Wall Street analysts maintain a positive outlook on Globe Life, with an average "Buy" rating and a consensus price target of $172.67.
Truist Financial Corp Invests $1.15 Million in Amer Sports, Inc. $AS
Truist Financial Corp initiated a new position in Amer Sports, Inc. (NYSE:AS) during the fourth quarter, acquiring 30,834 shares valued at approximately $1.15 million. This investment follows strong quarterly results from Amer Sports, which reported EPS of $0.31 and revenue of $2.10 billion, an increase of 28.5% year over year. Despite the positive earnings and an overall "Buy" consensus from analysts with a target price of $47.18, Amer Sports' stock experienced a 1.5% decline in Friday trading, and company insiders recently sold shares.
Essent Group and P&C Insurance Sector Q1 2026 Earnings Analysis - News and Statistics
Essent Group reported a strong Q1 2026, with revenue of $336.1 million, surpassing analyst expectations by 7.2%. The broader property and casualty insurance sector had a mixed quarter, with revenues beating consensus estimates by 1.9%, but share prices remained relatively stable. Stewart Information Services was identified as the top performer among the tracked stocks.
Globe Life (GL) Valuation Check After Recent Share Price Momentum And Bermuda Reinsurance Plans
Globe Life (GL) has seen positive share price momentum recently, with a 1-year total shareholder return of 28.1%. The company is considered modestly undervalued, trading at US$155.04 against a fair value of $172.10, partly due to plans for a Bermuda reinsurance affiliate expected to boost free cash flow and increase share repurchase capacity. Investors are advised to consider the risks associated with regulatory investigations and interest rate conditions, alongside potential rewards, before making investment decisions.
Globe Life (GL) Valuation Check After Recent Share Price Momentum And Bermuda Reinsurance Plans
Globe Life (GL) has seen positive share price momentum recently, with a 1-year total shareholder return of 28.1%. The stock is currently trading at US$155.04, which is considered a modest discount to its estimated fair value of $172 per share, driven partly by plans for a Bermuda reinsurance affiliate to increase free cash flow and financial flexibility. However, potential risks include regulatory investigations and interest rate fluctuations impacting investment income.
City of London (TDF) holds 8.94M Templeton Dragon shares, 35.5% stake
City of London Investment Management Company Limited has reported a beneficial ownership of 8,937,505 shares, or 35.5%, of Templeton Dragon Fund Inc. This disclosure was made in an amended Schedule 13G/A filing, indicating a passive investment approach rather than an active takeover intent. The shares are held directly by various City of London Funds and Segregated Accounts, with one specific Segregated Account entitled to over 5% of potential dividends or sale proceeds.
[144] GLOBE LIFE INC. SEC Filing
This article reports on Globe Life Inc.'s SEC Form 144 filing, which indicates a proposed sale of 12,000 shares of common stock by an individual. The shares were acquired through RSUs in March 2013 and have an aggregate market value of approximately $1.8 million. The filing shows no other securities sold by this person in the past three months.
174,761 Shares in Globe Life Inc. $GL Acquired by Arbejdsmarkedets Tillaegspension
Arbejdsmarkedets Tillaegspension (ATP) has acquired 174,761 shares of Globe Life Inc. (NYSE:GL) worth approximately $24.4 million, making it their 25th largest holding. Globe Life reported Q4 EPS of $3.43, slightly below analyst estimates, with revenue aligning at $1.56 billion, and reaffirmed its FY 2026 EPS guidance between $15.40 and $15.90. Analysts maintain a "Buy" consensus rating with a price target of $172.67, and the company recently declared a quarterly dividend of $0.33 per share.
Globe Life Inc. $GL Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al
VIRGINIA RETIREMENT SYSTEMS ET Al reduced its stake in Globe Life Inc. (NYSE:GL) by 31.7% in the fourth quarter, selling 9,200 shares and retaining 19,800 shares valued at $2.77 million. Despite this, analysts largely maintain a "Buy" rating for GL with an average price target of $172.67, and some firms recently upgraded the stock to "Strong Buy." Globe Life reported quarterly EPS of $3.43 (slightly below estimates) and revenue of $1.56 billion, which matched expectations and increased 5.3% year-over-year.
Globe Life Inc. (NYSE:GL) Given Average Rating of "Buy" by Brokerages
Globe Life Inc. (NYSE:GL) has received an average "Buy" rating from eleven brokerages, with a consensus 1-year price target of $172.67. Despite the latest quarterly EPS slightly missing estimates, revenue matched expectations and grew by 5.3% year-over-year. The insurance holding company recently traded near its 52-week high and announced a quarterly dividend of $0.33 per share.
NNN REIT (NYSE:NNN) Stock Crosses Above 200-Day Moving Average - Time to Sell?
NNN REIT (NYSE:NNN) recently saw its stock price move above its 200-day moving average, trading as high as $44.19 and closing near $43.75. Despite this, Wall Street analysts largely maintain a "Hold" rating with an average price target of $45.46. The company recently reported mixed quarterly results, missing EPS estimates but exceeding revenue expectations, and declared a quarterly dividend of $0.60 per share, offering a 5.5% annual yield.
Ameritas Advisory Services LLC Invests $1.84 Million in Citizens Financial Group, Inc. $CFG
Ameritas Advisory Services LLC has initiated a new position in Citizens Financial Group (NYSE:CFG) by purchasing 31,473 shares valued at approximately $1.84 million during the fourth quarter. Citizens Financial Group reported strong quarterly results, exceeding EPS estimates and achieving a 12% year-over-year revenue increase. The company also declared a quarterly dividend of $0.46 per share, and analysts maintain a "Moderate Buy" rating with an average price target of $70.88.
Globe Life trades above 200-day SMA: Time to buy the stock?
This article from MSN discusses whether it's a good time to buy Globe Life stock, given that its price is now trading above its 200-day Simple Moving Average (SMA). The 200-day SMA is a key technical indicator often used by investors to gauge long-term market trends and identify potential buy or sell signals.
Globe Life Inc. stock (US37959E1029): Life insurance provider with steady US market presence
Globe Life Inc., a leading US life and supplemental health insurer, maintains a strong position in the competitive insurance sector, focusing on middle-income families through direct marketing and agent networks. The company, headquartered in McKinney, Texas, offers a range of policies including life, supplemental health, and annuities, with its stock trading around $85.42 USD. Globe Life generates revenue through subsidiaries like American Income Life and Liberty National, emphasizing affordable, no-medical-exam policies and boasts a competitive edge in distribution scale and brand recognition as it serves over 4 million policyholders.
Globe Life Inc. stock outperforms competitors despite losses on the day
Globe Life Inc. (GL) shares fell 1.24% to $152.99 on Wednesday, despite outperforming competitors. The drop ended a two-day winning streak for the company's stock. The broader market experienced a mixed trading session, with the S&P 500 Index rising and the Dow Jones Industrial Average falling.
Globe Life Inc. stock (US37959E1029): CFO sells $4.2M in shares
Globe Life Inc.'s EVP & CFO, Thomas Kalmbach, sold 27,427 shares valued at over $4.19 million between May 8 and May 11, 2026, after exercising employee stock options. The transactions occurred when the stock was trading near its 52-week high. Globe Life Inc. focuses on life and supplemental health insurance in the US, known for its stable premium base and agent-driven sales model.
Banco Mundial recurre a Santander y otros privados para ampliar financiamiento en emergentes
The World Bank, through its private sector arm, the International Finance Corporation (IFC), is collaborating with private financial institutions like Deutsche Bank and Banco Santander to expand financing in emerging markets. This initiative involves a synthetic securitization of commercial financing worth $500 million, primarily for low-income and conflict-affected countries, marking the IFC's first such operation. This strategy allows the World Bank to significantly leverage its guarantees, facilitating more loans for development goals, especially amidst rising prices for energy and food.
GL Stock Chart | GLOBE LIFE INC (NYSE:GL)
This page provides the stock chart for GLOBE LIFE INC (NYSE:GL), displaying its current stock price and performance. Users can access various sections including technical and fundamental analysis, forecasts, and news. The chart itself can be viewed in daily, weekly, or monthly timeframes with different display options.
Globe Life Inc. stock (US37959E1029): Life insurance provider with steady US market presence
Globe Life Inc. maintains a strong position in the US life and supplemental health insurance sector, focusing on affordable policies for middle-income families through direct marketing and agent networks. The company, known for its no-medical-exam policies, relies heavily on life insurance premiums and supplemental health lines for revenue. While facing industry digital transformation pressures, Globe Life differentiates itself through its niche market and steady operational model.
Globe Life Insider Sold Shares Worth $4,195,007, According to a Recent SEC Filing
An insider at Globe Life has reportedly sold shares valued at $4,195,007, according to a recent SEC filing. The article also briefly mentions Unity Software's fourth-quarter financial results, including a 35% year-over-year revenue increase to $609 million, surpassing estimates, and a quarterly loss of 66 cents per share. However, the details of the Globe Life insider transaction are not provided in this snippet.
Globe Life EVP & CFO Kalmbach sells over $4.19 million in stock
Thomas Peter Kalmbach, EVP and CFO of GLOBE LIFE INC. (NASDAQ:GL), sold approximately $4.19 million worth of company stock on May 8 and May 11, 2026. These sales followed an exercise of employee stock options to acquire shares for about $3.44 million. Following these transactions, Kalmbach directly holds over 45,000 shares and indirectly holds over 1,100 shares through a 401(k) Plan.
Globe Life EVP & CFO Kalmbach sells over $4.19 million in stock
Thomas Peter Kalmbach, EVP and CFO of Globe Life Inc. (NASDAQ:GL), sold approximately $4.19 million in company stock across transactions on May 8 and May 11, 2026. These sales followed the exercise of employee stock options to acquire shares for about $3.44 million. Following these transactions, Kalmbach directly holds over 45,000 shares and indirectly holds over 1,100 shares in a 401(k) Plan.
Globe Life EVP & CFO Sold Shares Worth Over $4.1M
Thomas Peter Kalmbach, EVP & CFO of Globe Life (GL), sold 27,427 shares of company stock on May 8 and May 11, 2026, for a total of over $4.1 million at an average price of $152.88 per share. Following these transactions, Kalmbach directly owns 45,334 shares and indirectly holds 1,151 shares through a 401(k) plan.
[Form 4] GLOBE LIFE INC. Insider Trading Activity
A recent Form 4 SEC filing indicates significant insider trading activity at Globe Life Inc. (GL). EVP & CFO Kalmbach Thomas Peter sold a net of 27,427 shares totaling approximately $4.20 million through multiple transactions, including exercises of employee stock options and subsequent sales of common stock. After these transactions, Kalmbach Thomas Peter holds over 60,000 direct common shares and additional indirect shares.
